Dashboard
Manage Tickers

EXASEXACT SCIENCES CORP

Nasdaq exactsciences.com


$ 61.71 $ -0.57 (-0.92 %)    

Friday, 30-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 61.69
$ 61.67 x 100
$ 64.01 x 106
-- - --
$ 40.62 - $ 85.71
2,201,074
na
11.4B
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 04-26-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-16-2021 12-31-2020 10-K
16 10-27-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-21-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 07-30-2019 06-30-2019 10-Q
22 04-30-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 10-30-2017 09-30-2017 10-Q
29 07-25-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-26-2016 09-30-2016 10-Q
33 07-26-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-24-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-04-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-initiates-coverage-on-exact-sciences-with-overweight-rating-announces-price-target-of-75
Wells Fargo Initiates Coverage On Exact Sc...
08/27/2024 22:11:05

Wells Fargo analyst Brandon Couillard initiates coverage on Exact Sciences (NASDAQ:EXAS) with a Overweight rating and announ...

exact-sciences-launches-multi-cancer-early-detection-study-with-25k-patients-supported-by-fda-authorization
Exact Sciences Launches Multi-Cancer Early...
08/20/2024 11:07:56

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the first...

exact-sciences-shared-new-modeling-data-describing-the-projected-impact-of-the-cologuard-test-on-patients-health-care-professionals-and-the-us-health-care-system-since-its-fda-approval-10-years-ago
Exact Sciences Shared New Modeling Data De...
08/15/2024 11:10:39

9-health-care-stocks-whale-activity-in-todays-session
9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio
DoorDash And Exact Sciences Are Among Top ...
08/04/2024 14:32:50

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

crude-oil-moves-lower-moderna-shares-plunge
Crude Oil Moves Lower; Moderna Shares Plunge
08/01/2024 18:34:37

exact-sciences-analysts-slash-their-forecasts-after-q2-results
Exact Sciences Analysts Slash Their Foreca...
08/01/2024 18:14:37

benchmark-maintains-buy-on-exact-sciences-lowers-price-target-to-67
Benchmark Maintains Buy on Exact Sciences,...
08/01/2024 18:04:23

Benchmark analyst Bruce Jackson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $91 to $67.

dow-dips-over-500-points-ism-manufacturing-pmi-falls-in-july
Dow Dips Over 500 Points; ISM Manufacturin...
08/01/2024 16:06:46

air-products-posts-upbeat-earnings-joins-meta-exact-sciences-shake-shack-clearwater-analytics-and-other-big-stocks-moving-higher-on-thursday
Air Products Posts Upbeat Earnings, Joins ...
08/01/2024 15:42:35

stifel-maintains-buy-on-exact-sciences-lowers-price-target-to-82
Stifel Maintains Buy on Exact Sciences, Lo...
08/01/2024 14:34:33

Stifel analyst Daniel Arias maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 to $82.

exact-sciences-stock-climbs-after-strong-q2-results
Exact Sciences Stock Climbs After Strong Q...
07/31/2024 21:45:04

Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's ...

exact-sciences-maintains-full-year-2024-revenue-guidance-of-281b---285b-est-2829b
Exact Sciences Maintains Full-year 2024 Re...
07/31/2024 20:27:07

Raises full-year adjusted EBITDA guidance midpoint by $8M.

twinstrand-biosciences-enters-agreement-with-exact-sciences-to-exclusively-license-its-patent-estate-in-the-cell-free-nucleic-acid-sequencing-space
TwinStrand Biosciences Enters Agreement Wi...
07/31/2024 20:14:37

The license is related to TwinStrand Duplex Sequencing® error-correction technology, which increases the accuracy of next-gener...

exact-sciences-q2-2024-gaap-eps-009-beats-032-estimate-sales-699264m-beat-690003m-estimate
Exact Sciences Q2 2024 GAAP EPS $(0.09) Be...
07/31/2024 20:06:49

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.32...

fda-greenlights-guardant-healths-shield-blood-test-analyst-cautious-on-adoption
FDA Greenlights Guardant Health's Shield B...
07/29/2024 17:21:32

FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-appro...

peeling-back-the-layers-exploring-exact-sciences-through-analyst-insights
Peeling Back The Layers: Exploring Exact S...
07/17/2024 17:00:48

goldman-sachs-maintains-buy-on-exact-sciences-lowers-price-target-to-75
Goldman Sachs Maintains Buy on Exact Scien...
07/17/2024 16:02:22

Goldman Sachs analyst Matthew Sykes maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $88 t...

evercore-isi-group-maintains-outperform-on-exact-sciences-lowers-price-target-to-72
Evercore ISI Group Maintains Outperform on...
07/02/2024 15:22:14

Evercore ISI Group analyst Vijay Kumar maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target ...

geneoscopy-files-lawsuit-against-exact-sciences-for-breach-of-contract-and-misappropriation-of-trade-secrets-seeks-compensatory-and-punitive-damages-attorneys-fees-and-other-remedies-in-federal-court-in-delaware
Geneoscopy Files Lawsuit Against Exact Sci...
07/01/2024 12:21:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION